John T. Curnutte
2018
In 2018, John T. Curnutte earned a total compensation of $2.2M as Executive Vice President, Research and Development at Portola Pharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,700 |
|---|---|
| Option Awards | $1,041,754 |
| Salary | $461,116 |
| Stock Awards | $448,963 |
| Other | $42,208 |
| Total | $2,189,741 |
Curnutte received $1M in option awards, accounting for 48% of the total pay in 2018.
Curnutte also received $195.7K in non-equity incentive plan, $461.1K in salary, $449K in stock awards and $42.2K in other compensation.
Rankings
In 2018, John T. Curnutte's compensation ranked 5,263rd out of 14,244 executives tracked by ExecPay. In other words, Curnutte earned more than 63.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,263 out of 14,244 | 63rd |
Division Manufacturing | 1,987 out of 5,765 | 66th |
Major group Chemicals And Allied Products | 725 out of 2,128 | 66th |
Industry group Drugs | 606 out of 1,817 | 67th |
Industry Pharmaceutical Preparations | 468 out of 1,391 | 66th |
Source: SEC filing on April 19, 2019.
Curnutte's colleagues
We found six more compensation records of executives who worked with John T. Curnutte at Portola Pharmaceuticals in 2018.
2018
Scott Garland
Portola Pharmaceuticals
Chief Executive Officer
2018
William Lis
Portola Pharmaceuticals
Chief Executive Officer
2018
John Moriarty
Portola Pharmaceuticals
General Counsel
2018
Glenn Brame
Portola Pharmaceuticals
Executive Vice President, Chief Technical Operations Officer
2018
Ernie Meyer
Portola Pharmaceuticals
Chief Human Resources Officer
2018
Mardi Dier
Portola Pharmaceuticals